Is Poseida Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: PSTX) stock is to Buy PSTX stock.
Out of 1 analyst, 0 (0%) are recommending PSTX as a Strong Buy, 1 (100%) are recommending PSTX as a Buy, 0 (0%) are recommending PSTX as a Hold, 0 (0%) are recommending PSTX as a Sell, and 0 (0%) are recommending PSTX as a Strong Sell.
What is PSTX's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: PSTX) forecast ROE is N/A, which is considered weak.
What is PSTX's Price Target?
According to 1 Wall Street analyst that have issued a 1 year PSTX price target, the average PSTX price target is $15.00, with the highest PSTX stock price forecast at $15.00 and the lowest PSTX stock price forecast at $15.00.
The Wall Street analyst predicted that Poseida Therapeutics's share price could reach $15.00 by Aug 8, 2024. The average Poseida Therapeutics stock price prediction forecasts a potential upside of 689.47% from the current PSTX share price of $1.90.
What is PSTX's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: PSTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.07%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.